SenesTech reports strong revenue growth, successful efficacy trial of Evolve, and shift to using distributors for commercialization, signaling potential success for their innovative fertility control products and new strategy.
This news matters as it shows significant revenue growth for SenesTech, signaling potential success for their innovative fertility control products and new commercialization strategy. Investors and stakeholders should take note of the company's progress and the potential impact on the pest control industry.
